Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 377.38 K331.45 K529.56 K559.83 K9.28 M 10.7 M Research & development ————— — Operating income 2 M2.63 M1.86 M1.72 M-9.11 M -2.89 M Non-Operating Income, Total -7 268-6 000-38.01 K-41.67 K542.32 K 456.64 K Interest expense, net of interest capitalized 7 2686 00038.01 K—499.08 K — Non-Operating Income, excl. Interest Expenses 0-6 000-38.01 K-41.67 K542.32 K 456.64 K Unusual income/expense -7 268———— — Pretax income 2 M2.63 M1.82 M1.68 M-8.56 M -2.43 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 2 M2.63 M1.82 M1.68 M-8.56 M -2.43 M Discontinued operations ————— — Net income 2 M2.63 M1.82 M1.68 M-8.56 M -2.43 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 2 M2.63 M1.82 M1.68 M-8.56 M -2.43 M Basic earnings per share (Basic EPS) 0.060.080.060.06-0.24 -0.04 Diluted earnings per share (Diluted EPS) 0.060.080.060.06-0.24 -0.04 Average basic shares outstanding 31.34 M31.34 M31.34 M31.34 M36.02 M — Diluted shares outstanding 31.34 M31.34 M31.34 M31.34 M36.02 M — EBITDA 2 M2.63 M1.91 M1.68 M-10.6 M -4.38 M EBIT 2 M2.63 M1.86 M1.72 M-10.6 M -4.38 M Cost of revenue ————1.49 M — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 40738048.64 K-47.65 K249 1 623